Hvivo lands £5.2m contract with Asia-Pacific biotech to test RSV vaccine
Hvivo's human challenge trial will evaluate the safety, immunogenicity and efficacy of a vaccine candidate against RSV infection.
Source: siliconrepublic.com
Page 16 - Open Orphan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Open Orphan Today - Breaking & Trending Today
hVIVO phase I results for Imutex's mosquito vaccine published in eBioMedicine
HVIVO phase I results for Imutex's mosquito vaccine published in eBioMedicine
Source: directorstalkinterviews.com
Investegate |hVIVO PLC Announcements | hVIVO PLC: Imutex Phase I data published
Investegate announcements from hVIVO PLC, Imutex Phase I data published
Source: investegate.co.uk
'Way too many people worry too much about big cars and fancy houses' – Cathal Friel
Cathal Friel’s latest venture, Poolbeg Pharma, a clinical-stage infectious disease firm spun out of Open Orphan, aims to tap into the almost €200 billion infectious disease market
Source: businesspost.ie
Licensing deal could pave way for new treatments for metabolic diseases
Poolbeg Pharma acquired a licence from InsuCaps for an oral delivery technology for metabolic syndrome-related diseases.
Source: siliconrepublic.com